glp-1 agonist therapy consultation preparation Updated guidance for patients using GLP-1/GIP receptor agonists GLP-1 medications like Ozempic, Wegovy

Statistical modeling was used to analyze the association between GLP-1 exposure and breast cancer incidence

NAION and GLP-1 RAs Recent studies have indicated a possible link between GLP-1 receptor agonists semaglutide and liraglutide and an increased risk of NAION, or non-arteritic anterior ischemic optic neuropathy

P.RamasundarahettigeC.BranchK

1,5 Protein intake Dietary proteins are among the most potent natural stimulators of GLP-1 release

The new biology and pharmacology of glucagon

The incidence of acute pancreatitis, as confirmed by post-marketing monitoring data, are less than 0.1%, which is in line with the rates seen in the general diabetic population